22nd Century Group Announces Exercise of Existing Warrants and Fundraising

Business by 2FIRSTS.ai
22nd Century Group Announces Exercise of Existing Warrants and Fundraising
BioTech company 22nd Century Group, Inc. announced the exercise of existing options by shareholders, generating approximately $3.2 million in revenue.

According to a report published by Menafn on December 4th, the biotechnology company 22nd Century Group, Inc. (NASDAQ: XXII), based in Buffalo, New York, announced that some holders plan to exercise their existing stock options as part of the previously disclosed incentive stock option program.


During this exercise period, several existing stock option holders of the company purchased a total of 14,767,386 common shares at a reduced exercise price of $0.215 per share.


Currently, the company has received a total gross income of approximately 3.2 million dollars.


The newly appointed Chairman and CEO, Larry Firestone, has announced that this funding will serve as crucial operational capital to support the company's tobacco business and drive its restructuring efforts to enhance performance in the tobacco industry and reduce operational costs.


This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.